What is breast cancer endocrinology treatment?
Firstly, endocrine treatment is a treatment that addresses the intrauterine hormone imbalance of breast cancer. Estrogens and gestation hormones play a key role in the incidence and development of breast cancer, so that tumour cell growth can be inhibited by regulating the levels of these hormones. At present, endocrine treatment consists mainly of two types of anti-estrogen drugs and aromatic enzyme inhibitors. Second, endocrine treatment applies to hormonal positive breast cancer patients. These patients usually respond well to endocrine treatment and are better prepared. However, there are differences in the response of different patients, which may be related to their genetic background, tumour properties and treatment times. In addition, endocrine drugs commonly used in the clinical field include Moxiphine, Toremiphine, fluoride, etc. These drugs can inhibit the growth of tumour cells by inhibiting the activity of estrogen or pregnancy hormones through different mechanisms. For drug efficacy assessments, methods such as clinical assessment, visual examination and biomarker analysis are commonly used. In addition, emerging technologies such as gene sequencing and immunosuppressants provide new tools for the assessment of the efficacy of endocrine treatment. Despite the important role played by endocrine treatment in breast cancer treatment, challenges and unresolved issues remain. First, the response rate for endocrine treatment is still not ideal, with some patients not responding to treatment or having a shorter response time. Second, endocrine treatment is generally less effective in cases of relapse or transferal breast cancer. Finally, there are no specific endocrine treatments for certain specific types of breast cancer, such as triple-negative breast cancer. Future research could focus on the development of new endocrine drugs, the impact of tumour micro-environments on endocrine treatment responses, the exploration of joint applications for immunotherapy and endocrine treatment, and the use of genomics and cosmetic genetics to develop a deeper understanding of breast cancer incidence and development mechanisms. In general, endocrine treatment is one of the important tools for breast cancer treatment, and despite some challenges and unresolved issues, as research deepens, we believe that there will be more new drugs and treatments in the future that will provide better treatment options for breast cancer patients.
Breast cancer
